Log in to save to my catalogue

SARS-CoV-2-triggered mast cell rapid degranulation induces alveolar epithelial inflammation and lung...

SARS-CoV-2-triggered mast cell rapid degranulation induces alveolar epithelial inflammation and lung...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_423c8f44559f4a13b4f0ba6c8952936f

SARS-CoV-2-triggered mast cell rapid degranulation induces alveolar epithelial inflammation and lung injury

About this item

Full title

SARS-CoV-2-triggered mast cell rapid degranulation induces alveolar epithelial inflammation and lung injury

Publisher

London: Nature Publishing Group UK

Journal title

Signal transduction and targeted therapy, 2021-12, Vol.6 (1), p.428-428, Article 428

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

SARS-CoV-2 infection-induced hyper-inflammation links to the acute lung injury and COVID-19 severity. Identifying the primary mediators that initiate the uncontrolled hypercytokinemia is essential for treatments. Mast cells (MCs) are strategically located at the mucosa and beneficially or detrimentally regulate immune inflammations. In this study,...

Alternative Titles

Full title

SARS-CoV-2-triggered mast cell rapid degranulation induces alveolar epithelial inflammation and lung injury

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_423c8f44559f4a13b4f0ba6c8952936f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_423c8f44559f4a13b4f0ba6c8952936f

Other Identifiers

ISSN

2059-3635,2095-9907

E-ISSN

2059-3635

DOI

10.1038/s41392-021-00849-0

How to access this item